Cingulate Inc.

US$4.26As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CINGHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (64.64%)
Div yield —
ROE (198.74%)
Biotechnology
Beta (5Y) (0.89)
PE TTM —
TSR TTM 12.40%
Mkt cap US$61.95M
ROIC (74.43%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.66
9.41%
(55.71%)
Hold 10|5|2|11|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.06
0.06
0.06
15.26%
14.51%
17.35%
11.02%
Revenue$M
4.456
4.623
4.616
4.827
8.56%
6.78%
1.26%
8.67%
Peers (US$61.95M)
Cap (US$)
PE
61.70M
0.569x
61.82M
—
Capital
TTM
5Y
10Y
Leveragex
0.644
0.049
0.046
EBIT/Intx
1.723
0.152
0.187
Own earn%
121.28
46.75
38.49
Sh yield%
41.15
7.67
10.10
Owners
Insiders/Inst%
1.80
89.12
Short interest%
3.23
SBC / revenue%
2.03
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
12–20
$1 testx
0.0
Incr. ROIC%
13